AUTL Stock Price Chart
AUTL Stock Price Prediction
Autolus Therapeutics PLC
$1.59
-4.21%
$-0.06
At close: Jun 24, 16:00:00 GMT-4
$1.62
1.88%
$0.03
Post-market: Jun 24, 20:00:00 GMT-4
Back
Autolus Therapeutics PLC (AUTL) Stock Price Prediction
Key Stats
Prev.Close
$1.66
Open
$1.66
Day's Range
$1.58 - $1.68
52 week range
$1.17 - $2.7
Volume
1.0M
Avg.Volume
1.5M
Dividend yield
--
EPS (TTM)
-1.86
Market Cap
$431.1M
What is AUTL?
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. The company is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. The company has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
